Skip to main content

SGMO

Stock

SGMO

Stock
Health Care
Biotechnology

Performance overview

SGMO Price
Price Chart

Forward-looking statistics

Beta
1.98
Risk
100.00%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

for sangamo therapeutics, science is a means to develop new medicines with the potential to transform the lives of patients living with serious genetic diseases. our scientists are leaders in the discovery, research and development of technologies enabling gene-based therapeutic development. currently we are conducting clinical trials, including the first ever in vivo human genome editing studies. to learn more about sangamo, visit the our website at www.sangamo.com.

Company info

SectorHealth Care
IndustryBiotechnology
Employees462
Market cap$119.2M

Fundamentals

Enterprise value$125.9M
Revenue$63.8M
Revenue per employee—
Profit margin-124.61%
Debt to equity507.05

Security info

ExchangeNASDAQ
Type of shareCommon Stock
Earnings per share (EPS)-$0.36
Dividend per share—
Revenue per share$0.30
Avg trading volume (30 day)$3M
Avg trading volume (10 day)$4M
Put-call ratio—

Macro factor sensitivity

Growth+22.8
Credit+3.3
Liquidity-16.0
Inflation+19.1
Commodities+9.4
Interest Rates-0.8

Valuation

Dividend yield0.00%
PEG Ratio-2.40
Price to sales2.03
P/E Ratio-2.40
Enterprise Value to Revenue1.98
Price to book23.95

Upcoming events

Next earnings dayMay 13, 2025
Next dividend day—
Ex. dividend day—

News

Sangamo Therapeutics (SGMO) Reports Q1 Loss, Misses Revenue Estimates

Sangamo Therapeutics (SGMO) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to loss of $0.27 per share a year ago.

Zacks Investment Research (May 12, 2025)
Crude Oil Rises 1%; Sangamo Therapeutics Shares Plummet

U.S. stocks traded slightly lower midway through trading, with the Nasdaq Composite falling around 50 points on Tuesday.

Benzinga (December 31, 2024)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free